Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

EPIX holding history

ESSA Pharma Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EPIX overviewAll 13F holders of EPIXFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of EPIX by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−5,473−100.0%Sold outHolders
Q3 20255,473$1.05K<0.1%−6,548−54.5%ReducedHolders
Q2 202512,021$20.4K<0.1%−11,587−49.1%ReducedHolders
Q1 202523,608$37.3K<0.1%−72,006−75.3%ReducedHolders
Q4 202495,614$171.1K<0.1%+93,197+3,855.9%AddedHolders
Q3 20242,417$14.6K<0.1%+852+54.4%AddedHolders
Q2 20241,565$8.23K<0.1%−2,061−56.8%ReducedHolders
Q1 20243,626$30.8K<0.1%−1,269−25.9%ReducedHolders
Q4 20234,895$32.3K<0.1%+4,730+2,866.7%AddedHolders
Q3 2023165$510<0.1%−265−61.6%ReducedHolders
Q2 2023430$1.16K<0.1%−2,824−86.8%ReducedHolders
Q1 20233,254$9.66K<0.1%−3,268−50.1%ReducedHolders
Q4 20226,522$16.4K<0.1%+6,522NewHolders
Q3 20220$00.0%−28,551−100.0%Sold outHolders
Q2 202228,551$90.0K<0.1%−2,891−9.2%ReducedHolders
Q1 202231,442$194.0K<0.1%+329+1.1%AddedHolders
Q4 202131,113$442.0K<0.1%+16,227+109.0%AddedHolders
Q3 202114,886$119.0K<0.1%−43,154−74.4%ReducedHolders
Q2 202158,040$1.66M<0.1%+57,172+6,586.6%AddedHolders
Q1 2021868$25.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.